Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...

Gilead Sciences said on Monday its experimental HIV treatment met the main goal and was found to be statistically ...

Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...

Paper in @jclinicalinvest (bit.ly/497z6jo) by @HopkinsMedicine @JHUMed_ID finds patient living w/ #HIV has dramatic drop in ...

HIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment ...

A natural vitamin A transporter, RBP4, can awaken latent HIV through NF-κB signalling, offering a new angle for cure strategies. Human immunodeficiency virus (HIV) is a virus that attacks key immune ...

Scientific advances offer hopes of a cure but ‘devastating’ foreign aid cuts leave countries battling Aids without funds ...

An Open and Aids Awareness Day focused on staying on medication and using health services after gender-based violence.

More than 50 people were honored at Government House yesterday for their efforts in the fight against HIV/AIDS in The Bahamas ...

The Trump administration's funding cuts to PEPFAR and USAID disrupted global HIV treatment and prevention, threatening progress made over decades. Lenacapavir's FDA approval as a long-acting ...

The U.S. commitment to ending HIV is shaken. For the first time, we didn't formally mark World AIDS Day. And Trump has cut ...